These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 30674257

  • 21. Formulation, Characterization, and Pharmacokinetic Studies of 6-Gingerol-Loaded Nanostructured Lipid Carriers.
    Wei Q, Yang Q, Wang Q, Sun C, Zhu Y, Niu Y, Yu J, Xu X.
    AAPS PharmSciTech; 2018 Nov; 19(8):3661-3669. PubMed ID: 30324361
    [Abstract] [Full Text] [Related]

  • 22. Design, characterization and in vivo evaluation of nanostructured lipid carriers (NLC) as a new drug delivery system for hydrochlorothiazide oral administration in pediatric therapy.
    Cirri M, Maestrini L, Maestrelli F, Mennini N, Mura P, Ghelardini C, Di Cesare Mannelli L.
    Drug Deliv; 2018 Nov; 25(1):1910-1921. PubMed ID: 30451015
    [Abstract] [Full Text] [Related]

  • 23. Baicalein loaded in tocol nanostructured lipid carriers (tocol NLCs) for enhanced stability and brain targeting.
    Tsai MJ, Wu PC, Huang YB, Chang JS, Lin CL, Tsai YH, Fang JY.
    Int J Pharm; 2012 Feb 28; 423(2):461-70. PubMed ID: 22193056
    [Abstract] [Full Text] [Related]

  • 24. Design and evaluation of lipoprotein resembling curcumin-encapsulated protein-free nanostructured lipid carrier for brain targeting.
    Meng F, Asghar S, Xu Y, Wang J, Jin X, Wang Z, Wang J, Ping Q, Zhou J, Xiao Y.
    Int J Pharm; 2016 Jun 15; 506(1-2):46-56. PubMed ID: 27094357
    [Abstract] [Full Text] [Related]

  • 25. Preparation and characterization of dutasteride-loaded nanostructured lipid carriers coated with stearic acid-chitosan oligomer for topical delivery.
    Noor NM, Sheikh K, Somavarapu S, Taylor KMG.
    Eur J Pharm Biopharm; 2017 Aug 15; 117():372-384. PubMed ID: 28412472
    [Abstract] [Full Text] [Related]

  • 26. Physicochemical characterization and in vivo bioluminescence imaging of nanostructured lipid carriers for targeting the brain: apomorphine as a model drug.
    Hsu SH, Wen CJ, Al-Suwayeh SA, Chang HW, Yen TC, Fang JY.
    Nanotechnology; 2010 Oct 08; 21(40):405101. PubMed ID: 20823498
    [Abstract] [Full Text] [Related]

  • 27. Nose to Brain Delivery of Rivastigmine by In Situ Gelling Cationic Nanostructured Lipid Carriers: Enhanced Brain Distribution and Pharmacodynamics.
    Wavikar P, Pai R, Vavia P.
    J Pharm Sci; 2017 Dec 08; 106(12):3613-3622. PubMed ID: 28923321
    [Abstract] [Full Text] [Related]

  • 28. Development of nose-to-brain delivery of ketoconazole by nanostructured lipid carriers against cryptococcal meningoencephalitis in mice.
    Du W, Li H, Tian B, Sai S, Gao Y, Lan T, Meng Y, Ding C.
    Colloids Surf B Biointerfaces; 2019 Nov 01; 183():110446. PubMed ID: 31465938
    [Abstract] [Full Text] [Related]

  • 29. Formulation optimization, in vitro and in vivo evaluation of agomelatine-loaded nanostructured lipid carriers for augmented antidepressant effects.
    Gul M, Shah FA, Sahar NU, Malik I, Din FU, Khan SA, Aman W, Choi HI, Lim CW, Noh HY, Noh JS, Zeb A, Kim JK.
    Colloids Surf B Biointerfaces; 2022 Aug 01; 216():112537. PubMed ID: 35561634
    [Abstract] [Full Text] [Related]

  • 30. Transferrin-modified nanostructured lipid carriers as multifunctional nanomedicine for codelivery of DNA and doxorubicin.
    Han Y, Zhang Y, Li D, Chen Y, Sun J, Kong F.
    Int J Nanomedicine; 2014 Aug 01; 9():4107-16. PubMed ID: 25187713
    [Abstract] [Full Text] [Related]

  • 31. QbD-driven development and evaluation of nanostructured lipid carriers (NLCs) of Olmesartan medoxomil employing multivariate statistical techniques.
    Beg S, Saini S, Bandopadhyay S, Katare OP, Singh B.
    Drug Dev Ind Pharm; 2018 Mar 01; 44(3):407-420. PubMed ID: 29048242
    [Abstract] [Full Text] [Related]

  • 32. Lactoferrin-loaded nanostructured lipid carriers (NLCs) as a new formulation for optimized ocular drug delivery.
    Varela-Fernández R, García-Otero X, Díaz-Tomé V, Regueiro U, López-López M, González-Barcia M, Isabel Lema M, Javier Otero-Espinar F.
    Eur J Pharm Biopharm; 2022 Mar 01; 172():144-156. PubMed ID: 35183717
    [Abstract] [Full Text] [Related]

  • 33. Agranulocytosis-Protective Olanzapine-Loaded Nanostructured Lipid Carriers Engineered for CNS Delivery: Optimization and Hematological Toxicity Studies.
    Gadhave DG, Tagalpallewar AA, Kokare CR.
    AAPS PharmSciTech; 2019 Jan 02; 20(1):22. PubMed ID: 30604305
    [Abstract] [Full Text] [Related]

  • 34. Nanostructured lipid carriers enhance the bioavailability and brain cancer inhibitory efficacy of curcumin both in vitro and in vivo.
    Chen Y, Pan L, Jiang M, Li D, Jin L.
    Drug Deliv; 2016 May 02; 23(4):1383-92. PubMed ID: 26066035
    [Abstract] [Full Text] [Related]

  • 35. Implications of formulation design on lipid-based nanostructured carrier system for drug delivery to brain.
    Salunkhe SS, Bhatia NM, Bhatia MS.
    Drug Deliv; 2016 May 02; 23(4):1306-16. PubMed ID: 25080227
    [Abstract] [Full Text] [Related]

  • 36. Preparation of tripterine nanostructured lipid carriers and their absorption in rat intestine.
    Zhou L, Chen Y, Zhang Z, He J, Du M, Wu Q.
    Pharmazie; 2012 Apr 02; 67(4):304-10. PubMed ID: 22570936
    [Abstract] [Full Text] [Related]

  • 37. Nanostructured lipid carriers with exceptional gastrointestinal stability and inhibition of P-gp efflux for improved oral delivery of tilmicosin.
    Zhang Q, Yang H, Sahito B, Li X, Peng L, Gao X, Ji H, Wang L, Jiang S, Guo D.
    Colloids Surf B Biointerfaces; 2020 Mar 02; 187():110649. PubMed ID: 31767412
    [Abstract] [Full Text] [Related]

  • 38. Nanostructured lipid carriers for the topical delivery of tretinoin.
    Ghate VM, Lewis SA, Prabhu P, Dubey A, Patel N.
    Eur J Pharm Biopharm; 2016 Nov 02; 108():253-261. PubMed ID: 27519827
    [Abstract] [Full Text] [Related]

  • 39. Hyaluronic acid modified nanostructured lipid carriers for transdermal bupivacaine delivery: In vitro and in vivo anesthesia evaluation.
    Yue Y, Zhao D, Yin Q.
    Biomed Pharmacother; 2018 Feb 02; 98():813-820. PubMed ID: 29571251
    [Abstract] [Full Text] [Related]

  • 40. Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery.
    Wu M, Fan Y, Lv S, Xiao B, Ye M, Zhu X.
    Drug Deliv; 2016 Oct 02; 23(8):2720-2725. PubMed ID: 26203691
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.